πŸ‡ΊπŸ‡Έ FDA
Patent

US 9341619

Hyposialylation disorders

granted A61KA61K45/06

Quick answer

US patent 9341619 (Hyposialylation disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K45/06